This is seemingly at odds with recent research into CTC-based PDAC prognostics, as discussed previously, whereby several groups identified CTCs adopting a mesenchymal EpCAM-negative phenotype were associated with poorer prognosis, consistent with the invasive characteristics associated with mesenchymal tumour cells [69]. This evidence concerns the gene EPCAM and neoplasm.